Credit: Shutterstock photoAbiomed Inc ( ABMD ) files its latest 10-K with SEC for the fiscal year ended on March 31, 2017. Abiomed Inc is engaged in providing mechanical circulatory support devices and it offers a continuum of care in heart recovery to heart failure patients. Abiomed Inc has a market cap of $5.93 billion; its shares were traded at around $135.88 with a P/E ratio of 117.12 and P/S ratio of 14.71.
For the last quarter Abiomed Inc reported a revenue of $124.7 million, compared with the revenue of $93.96 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $445.3 million, an increase of 35.1% from last year. For the last five years Abiomed Inc had an average revenue growth rate of 28.3% a year.
The reported diluted earnings per share was $1.17 for the year, an increase of 37.6% from previous year. Over the last five years Abiomed Inc had an EPS growth rate of 87.8% a year. The Abiomed Inc enjoyed an operating margin of 20.24%, compared with the operating margin of 19.76% a year before. The 10-year historical median operating margin of Abiomed Inc is -4.93%. The profitability rank of the company is 6 (out of 10).
At the end of the fiscal year, Abiomed Inc has the cash and cash equivalents of $39.0 million, compared with $48.2 million in the previous year. The long term debt was $15.5 million. Abiomed Inc has a financial strength rank of 7 (out of 10).
At the current stock price of $135.88, Abiomed Inc is traded at 123.4% premium to its historical median P/S valuation band of $60.83 . The P/S ratio of the stock is 14.71, while the historical median P/S ratio is 6.59. The stock gained 35.41% during the past 12 months.
Directors and Officers Recent Trades:
- VP, Global Sales & Marketing Michael G Howley sold 18,279 shares of ABMD stock on 05/16/2017 at the average price of $133.56. The price of the stock has increased by 1.74% since.
- VP, Global Sales & Marketing Michael G Howley sold 600 shares of ABMD stock on 05/08/2017 at the average price of $132.84. The price of the stock has increased by 2.29% since.
- COO David M Weber sold 21,250 shares of ABMD stock on 05/08/2017 at the average price of $130.89. The price of the stock has increased by 3.81% since.
- Director Dorothy E Puhy sold 13,500 shares of ABMD stock on 05/08/2017 at the average price of $131.12. The price of the stock has increased by 3.63% since.
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .
This article first appeared on GuruFocus .
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
